Fifth Annual Orlando Clinical Updates in Inflammatory Bowel Disease

May 4, 2019
JW Marriott
4040 Central Florida Pkwy
Orlando, FL 32837

Course Director

Udayakumar Navaneethan, MD, FACG
Director, IBD Center and Interventional IBD Unit, Florida Hospital
Center for Interventional Endoscopy
Assistant Professor of Internal Medicine
University of Central Florida College of Medicine

Guest Faculty

Gary R. Lichtenstein, MD
Director, Inflammatory Bowel Disease Center
Professor of Medicine,
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

David Schwartz, MD
Director, Inflammatory Bowel Disease Center
Professor of Medicine,
Vanderbilt University Medical Center
Nashville, Tennessee

Yehuda Chowers, MD
Director, Gastroenterology Institute
Director, Clinical Research Institute at Rambam (CRIR)
Professor of Medicine,
Rambam Health Care Campus
Department of Gastroenterology
Rambam, Israel

Raymond Cross, MD, MS, AGAF
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Director of the Inflammatory Bowel Disease Program
University of Maryland School of Medicine
Co-Director Digestive Health Center
University of Maryland Medical Center
Baltimore, Maryland

Shazia Beg, MD
Assistant Professor of Internal Medicine
Assistant Program Director, Rheumatology
University of Central Florida College of Medicine
Orlando, Florida

Florida Hospital Faculty

Ji Young Bang, MD
Robert Hawes, MD
Muhammad Hasan, MD
Shyam Varadarajulu, MD
John Monson, MD

Target Audience

Gastroenterologists, Colo-rectal Surgeons, Gastroenterology trainees, Internists, Advanced Nurse Practitioners and Nurses


JW Marriott
4040 Central Florida Pkwy
Orlando, FL 32837

Registration Information

Course Fee: $50
To register, call 407-303-9863 for more information

CME Information

Florida Hospital is accredited by the Florida Medical Association to provide continuing medical education for physicians. Florida Hospital designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Each physician should claim only those hours of credit commensurate with the extent of their participation in the activity.

7:30 - 7:55 Registration and Continental Breakfast
7:55 - 8:00 Welcome by Udayakumar Navaneethan, MD
8:00 - 8:40 Positioning anti-TNFs in the Management of Moderate to Severe Inflammatory Bowel Disease - Gary Lichtenstein, MD
8:40 - 8:45 Questions
8:45 - 9:25 Use of anti-adhesion molecules and anti-IL-12/23 medications in the Management of Inflammatory Bowel Disease - David Schwartz, MD
9:25 - 9:30 Questions
9:30 - 9:50 Biosimilars in IBD patients - Hope of Hype? - Yehuda Chowers, MD
9:50 - 9:55 Questions
9:55 - 10:15 Positioning Tofacitinib in the treatment of UC and future therapies in the horizon - Raymond Cross, MD
10:15 - 10:20 Questions
10:20 - 10:40 Rheumatologist in the co-management of IBD patients - Shazie Beg, MD
10:40 - 10:45 Questions
10:45 - 11:00 Coffee Break
11:00 - 11:20 Therapeutic Drug Monitoring in clinical practoce - Pro-active vs Reactive - Gary Lichentstein, MD
11:20 - 11:25 Questions
11:25 - 11:45 How to manage biologics in the peri-operative period and management of Crohn's disease after surgery - Raymond Cross, MD
11:45 - 11:50 Questions
11:50 - 12:25 Treat to target: Incorporating endoscoy in the optimal management of IBD and endoscopic management of IBD complications - Udayakumar Navaneethan, MD
12:25 - 12:30 Questions
12:30 - 1:15 Lunch Break
1:15 - 1:40 Chromoendoxcopy in cancer serveillance in IBD - How to do it and incorporating in clinical practice - Udayakumar Navaneethan, MD
1:40 - 1:45 Questions
1:45 - 2:15 Perianal CD-Debate
1:45 - 2:00 Pro-medications: David Schwartz, MD
2:00 - 2:15 Pro-surgery: John Monson, MD
2:15 - 2:35 When can we de-escalate therapy in IBD; Immunomodulation in IBD - Yehuda Chowers, MD
2:35 - 2:40 Questions
2:40 - 3:10 State of the Art: The future algorighms in IBD management - INtegrating current and future therapies - Gary Lichtenstein, MD
3:10 - 3:15 Questions
3:15 - 3:45 Looing into the crystal ball: Can we predict treatment response in IBD - "Personalized medicine in IBD" - Yehuda Chowers, MD
3:45 - 3:50 Questions and Concluding Remarks


The objective of this event is to provide participants a comprehensive education in Inflammatory Bowel Disease evaluation and management. The program covers five major topics.

  • Treatment options for the medical management of ulcerative colitis and Crohn’s disease
  • Understand the role of surgery in the management of complications of Crohn’s disease
  • How to evaluate, manage and monitor treatment of patients with IBD
  • Diagnosing colon dysplasia/cancer in IBD patients and use of chromoendoscopy
  • Peri-operative management of IBD

American Disabilities Act

Florida Hospital is committed to making its activities accessible to all individuals. If you have a disability, please submit a description of your needs, along with your registration, to assure that you will be able to participate in this activity.